Anaplastic Large Cell Lymphoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) HC (1) | CD30 + | Anaplastic Large Cell Lymphoma | Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone | |
| FDA (1) | CD30 + | Anaplastic Large Cell Lymphoma | Brentuximab vedotin | |
| FDA (1) | v::ALK | Anaplastic Large Cell Lymphoma | Crizotinib |